Disease transmission and immune response
Introducido| English | Significado |
|---|---|
| pathogen/ˈpæθədʒn/ | patógeno |
| antigen/ˈæntɪdʒen/ | antígeno |
What would explain this observation?
- An antibiotic may help against a bacterial infection but fail against a viral illness. Treatment depends on the causal organism and the evidence supporting diagnosis.
Build the model
- Pathogens 病原体 cause infectious disease.
- Physical barriers, phagocytosis and specific immune responses reduce infection.
- Antibodies bind particular antigens 抗原.
- Vaccination exposes the immune system to antigen safely enough to develop memory.
- pathogen: An agent that causes disease.
- antigen: A structure recognized by a specific immune response.
What explains the spread of antibiotic resistance?
Dificultad 1/5 · 100 monedas + un pequeño bono en el primer intento de hoy
Resistance spreads because resistant variants survive antibiotic treatment and reproduce, so their proportion rises; this is selection acting on existing variation. Bacteria do not change their genes deliberately, and antibiotics have no effect that turns viruses into bacteria.
Match each technical term to its precise meaning.
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
Use the definitions to distinguish related quantities and processes.
Choose evidence that can test it
- After vaccination, memory cells can support a faster secondary response.
- Antibiotic resistance arises through heritable variation and selection; an individual bacterium does not choose to become resistant because it needs to survive.
In the lab: Use published infection data to compare rates per equal population size. Distinguish prevalence at a time from new cases over a period. In school, use safe simulations or approved cultures rather than collecting unknown pathogens.
Which two habits make the investigation or model in this case more defensible?
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
Stating the conditions and assumptions lets others repeat the work exactly, and recording the supporting evidence lets them check the conclusion. Hiding disagreeing results removes the evidence that could challenge a wrong conclusion, and one measurement can never establish a wider claim.
Work from known quantities
- Known: 18 cases occur in 900 people.
- Rate per 1,000 = cases / population × 1,000.
- Rate = 18/900 × 1,000 = 20 cases per 1,000.
- A second group with 10 cases in 250 people has 40 per 1,000, even though it has fewer cases.
Your turn: 12 cases occur among 600 people. Find cases per 1,000 people.
Fewer cases can still mean a higher case proportion
Compare the lesson's 18 cases among 900 people with 10 among 250. Standardize both denominators to 1,000, then double A's case count and population together to see why its proportion stays unchanged.
12 cases occur among 600 people. Find cases per 1,000 people.
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
The result is 20 . Known: 12 cases among 600 people. Use rate per 1,000 = cases / population x 1,000. Rate = 12/600 x 1,000 = 20 cases per 1,000 people. Rates per equal population size allow a fair comparison between groups of different size.
Check the conclusion and its limits
- Antibiotics do not act on viruses in the same way they act on bacteria.
- A vaccine is not an immediate cure for an established infection.
Not true: Every antibiotic is effective against every viral infection. Antibiotics act on bacterial structures and processes that viruses do not have, so they cannot cure a viral infection. Using them against viruses adds selection pressure for resistance without benefit.
- Pathogens cause infectious disease.
- After vaccination, memory cells can support a faster secondary response.
- Watch for: antibiotics do not act on viruses in the same way they act on bacteria.
Every antibiotic is effective against every viral infection.
Dificultad 1/5 · 100 monedas + un pequeño bono en el primer intento de hoy
Antibiotics act on bacterial structures and processes that viruses do not have, so they cannot cure a viral infection. Using them against viruses adds selection pressure for resistance without benefit.
An agent that causes disease: write the technical term.
Dificultad 1/5 · 100 monedas + un pequeño bono en el primer intento de hoy
pathogen means An agent that causes disease.
Write from a rate with a stated denominator
- In the original written case, 8 cases among 500 people gives $8/500\times1000=16$ cases per 1000. A smaller count does not establish a smaller affected fraction when group sizes differ. Record the population and time definition before comparing reports; the number of newly recorded cases during an interval differs from the number currently affected at a particular time.
- This expansion teaches the HL-only A2.3 viruses unit; there is no SL copy of this unit. It develops particle structure, host dependence, lambda pathways and viral evolution. All new numerical populations and image measurements are invented teaching examples, not patient records, outbreak measurements or fixed properties of named viruses.
8 cases occur among 500 people. What is the rate per 1000 people, and why is the raw case count not enough for a comparison?
8 over 500 is 0.016, and 0.016 times 1000 is 16 per 1000.
In the written case, 8 cases occur among 500 people. What is the number of cases per 1000 people?
Dificultad 1/5 · 100 monedas + un pequeño bono en el primer intento de hoy
8/500 × 1000 = 16 cases per 1000. Compare matching population and time definitions; a smaller count alone does not establish a smaller affected fraction.
Distinguish a particle from a cellular organism
- A virion is a complete viral particle outside a host cell. Its nucleic-acid genome is protected by a protein capsid; some viruses also have a lipid envelope with viral surface proteins. A virus has no ribosome-containing cytoplasm and complete autonomous cellular metabolism. New particles assemble from components; they do not enlarge into cells and divide by bacterial binary fission.
- The packaged genome may be DNA or RNA and may be single- or double-stranded, depending on the virus. Replication can produce other nucleic-acid intermediates inside a host, so distinguish the packaged genome from those intermediates. Some virions carry enzymes needed early in infection; carrying an enzyme does not remove dependence on host translation, energy and materials.
Compare lambda, coronavirus and HIV by organization
- Lambda infects suitable Escherichia coli bacteria and packages double-stranded DNA in a head with a long non-contractile tail; it lacks a lipid envelope. Coronaviruses have enveloped particles with surface spike proteins and a single-stranded RNA genome. Mature HIV has an envelope and a conical capsid, packaging two RNA genome copies with enzymes including reverse transcriptase. Colour in the diagram identifies components, not natural microscopic appearance.
- A suitable surface receptor can support attachment, but successful infection also needs entry and later cellular conditions. Host range is a relationship between viral components and cells, not a virus choosing a preferred victim. One spherical model does not represent every capsid, envelope or genome. Lambda's tail should not be described as the contractile syringe of a different phage model.

Separate printed size from resolving power
- An invented particle is 9.0 mm across in an image and 90 nm in reality. Since one millimetre is one million nanometres, image length is $9.0\times10^6$ nm. Magnification is $(9.0\times10^6)/90=100\,000$, with no unit. A second 6.0 mm image of a 120 nm particle has magnification 50,000.
- Enlarging a picture does not reveal details that the instrument never resolved. Ordinary light microscopy would not resolve the internal capsid and genome as drawn here. An electron micrograph's added colour is also not direct evidence of natural particle colour. Use the actual image's scale and method before drawing a structural conclusion.
An invented particle image measures 9.0 mm and the actual particle is 90 nm across. Find magnification.
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
Convert 9.0 mm to 9.0 million nm. Divide by 90 nm to obtain magnification 100,000 times, a dimensionless ratio. Enlargement does not prove that every feature was resolved.
Follow host-dependent production and assembly
- Infection connects entry of viral information, expression of viral proteins, genome copying, assembly and release. Host ribosomes translate viral messages, while host resources supply building materials and energy. Viral and host enzymes contribute differently in different viruses; a functional outline does not make every genome follow one identical molecular pathway.
- Release can occur through lysis or budding and related membrane processes. Budding can supply an envelope containing viral proteins. Antibiotics target bacterial structures or processes, which are not present as an autonomous system in a virion; antiviral mechanisms instead target stages of infection or replication. Neither category is universally effective against every agent, and these distinctions describe biology rather than selecting a treatment for an individual.
Track lambda through the lytic pathway
- Lambda is a temperate bacteriophage. In the lytic pathway it attaches to a suitable bacterial surface and its DNA enters. Viral genes are expressed, DNA is copied and proteins are synthesized using host resources. Genomes are packaged into new heads, tails are added and phage-directed processes disrupt the bacterial envelope to release progeny particles.
- Distinguish genome replication from assembly of particles and from the number of infected cells. The original phage is not a miniature cell growing until it splits, and its whole head and tail are not injected into the bacterium. The NCBI lambda account describes the alternative infection pathways; the existence of one pathway does not mean every infection must immediately lyse its host.
Estimate a burst under a single-cycle model
- In an invented assay, 80 infected bacterial cells lyse and yield 4800 newly produced infectious units. Input particles have been removed and a second infection cycle is excluded. Mean burst size is $4800/80=60$ infectious units per infected cell. This is an average for that model, not a universal yield for all viruses or every cell.
- A plaque-based assay counts infectious units under its conditions, not necessarily every physical particle: some particles may fail to infect. If residual input particles or another infection cycle contributes to the measured total, simply dividing that total by the original infected-cell count no longer isolates one burst. State what was counted and which assumptions justify the denominator.
In an invented single-cycle model, 80 infected bacteria lyse and release 4800 newly produced infectious units. Input particles were removed and no second cycle occurs. Find mean burst size.
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
4800/80 = 60 infectious units per infected cell on average under these assumptions. Infectious-unit counts need not equal every physical particle.
Follow integrated DNA through lysogeny
- In lambda lysogeny, viral DNA integrates into the bacterial chromosome as a prophage. Regulation suppresses immediate lytic production, while the bacterium can copy its chromosome and divide, carrying the integrated sequence into descendants. A lysogen is the bacterium carrying the prophage; a prophage is not a fully assembled particle hiding inside a nucleus.
- Bacteria have no membrane-bound nucleus. Under suitable induction conditions, lambda can leave the integrated state and enter the lytic pathway, followed by gene expression, copying, assembly and release. This is a regulated change, not a deliberate decision. The OpenStax viral-life-cycle account distinguishes these pathways. Not every virus integrates, and HIV integration is not simply the lambda life cycle.

Count descendant bacteria without inventing released particles
- Begin with one lysogen carrying one integrated prophage. In a simplified model with complete binary division, no death, no induction and no prophage loss, four rounds produce $2^4=16$ descendant bacteria carrying the sequence. Six rounds would produce $2^6=64$. The assumptions concern bacterial reproduction and inheritance of DNA.
- Neither result establishes that 16 or 64 free phage particles were released. The counted entities are bacteria containing integrated viral DNA. A lytic burst calculation counts a different entity through a different process. Labelling the axis or answer “virus number” without specifying particles, genomes or infected cells can therefore produce a serious interpretation error.
One lysogen carrying an integrated prophage completes four rounds of binary division. Assume no induction, loss or death. How many descendant bacteria carry the prophage?
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
2⁴ = 16 bacteria. This is inheritance of integrated DNA during bacterial division, not a count of free particles released by lysis.
Explain HIV's RNA-to-DNA step
- HIV carries reverse transcriptase, which produces DNA from its RNA genome during infection. Viral integrase supports insertion of viral DNA into host DNA. Host transcription and translation can then contribute to making viral RNA and proteins, followed by assembly, budding and maturation. NIH's life-cycle explanation distinguishes these stages rather than treating reverse transcription as ordinary DNA-to-RNA transcription.
- HIV's packaged RNA and its integrated DNA are different molecular forms in the cycle. Integration does not make the whole particle an integrated organelle or remove host dependence. Errors and variation during copying, together with large populations and selection, complicate immune recognition and control. Their effects depend on the variant and environment; a new mutation is not automatically advantageous.
Evaluate possible multiple origins without claiming a witnessed history
- Viruses differ widely in genomes, replication systems, capsids and host relationships. Proposed origins include genetic elements escaping cellular systems and parasites losing functions as dependence increased. Different routes may apply to different groups, while exchanges of genes complicate reconstruction. Diversity is evidence to analyse, not an exact historical account of the origin of each virus.
- Similar functions can also favour similar structures independently through convergent evolution. A protective shell alone does not establish one recent common viral ancestor. Compare several molecular and structural features and consider alternative histories. Using the same cellular genetic code for expression does not mean all viral genomes contain identical genes or arose in an identical way.
Connect variation with differential reproductive success
- Copying errors and other genetic changes create heritable variants; they do not arise because a virus knows which future change it needs. Many variants are neutral or harmful. If an immune response or an antiviral pressure reduces one variant's reproductive success more than another's, their proportions can change across generations. The advantage is conditional on the environment.
- In an invented population, resistant variants change from 20 among 1000 particles to 40 among 100. Their fraction rises from $20/1000\times100=2\%$ to $40/100\times100=40\%$: 38 percentage points, or a twentyfold fraction. The resistant count doubled while total count fell 90%. A higher resistant fraction and a lower total burden can occur together; neither measurement should replace the other.

After a selective pressure in an invented population, 40 of 100 particles have a resistant variant. What percentage have it?
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
40/100 × 100 = 40%. Previously 20/1000 gave 2%. The fraction is twentyfold higher, while the resistant count doubled and the total count fell by 90%.
Distinguish influenza antigenic drift from shift
- Antigenic drift involves mutations that can change influenza surface antigens over time. Existing antibodies may recognize changed antigens less effectively, although an individual mutation need not alter recognition significantly. Influenza A and B undergo drift. CDC distinguishes drift and shift as different processes rather than simply two labels for a virus making more copies.
- Antigenic shift is an abrupt major antigenic change in influenza A. Reassortment can occur when different influenza viruses coinfect a cell and progeny acquire a new combination of genome segments. It differs from accumulating point mutations. A major change does not automatically establish efficient human-to-human transmission, and not every genetic change creates a new pandemic. State the mechanism and the evidence needed for the wider claim.
Finish with the correct entity and comparison
- For a viral question, identify whether the evidence concerns a virion, genome, infected cell, infectious unit or population fraction. Draw an appropriate particle and name its packaged genome; follow the specific lifecycle rather than applying one diagram to every virus. Separate a new variant arising from the selection that changes its representation.
- For infection comparisons, use matching population and time definitions and distinguish counts from rates. For evolution, state variation, inheritance and differential reproductive success. For historical origins, compare several lines of evidence and acknowledge uncertainty. A structural diagram, one sequence match or one large count cannot by itself establish every biological conclusion.
Explain how heritable variation and selection differ, and distinguish influenza antigenic drift from shift without assuming every changed virus causes a pandemic.
Name the mechanism first, then explain which additional biological properties and evidence a wider claim would require.
Distinguish a pathogen from an infection outcome
- A pathogen causes disease. Pathogenic bacteria are prokaryotic cells; pathogenic fungi and protists are eukaryotic cells; viruses are acellular and replicate through hosts. Most microorganisms are not pathogens. Infection can be present without obvious disease, while association with illness alone does not establish its cause.
- Entry, establishment and harmful effects are different stages. A control that blocks entry need not work by killing an agent already inside. Identify the organism or agent, its route and the outcome measured before comparing immune responses, treatments or infection statistics.
Connect physical and chemical barriers
- Intact skin limits entry through a closely packed, tough surface; damage can open a route. Airway mucus traps particles, and cilia move it towards removal. Tears and saliva wash surfaces and contain antimicrobial components such as lysozyme; stomach acidity inhibits many swallowed organisms. No barrier guarantees destruction of every pathogen.
- Historical comparisons tested routes before all mechanisms were known: Semmelweis examined childbed-fever deaths and hand disinfection; Snow compared cholera mortality with water supply. The reasoning connects a changed exposure with an outcome, while checking comparison groups and alternative explanations rather than treating a famous name as proof.
Trace clotting without turning blood cells into fibrin
- At vessel damage, platelets adhere, activate and recruit others into a plug. Platelets are cell fragments, distinct from red cells and antibodies. They also support clotting-factor reactions that amplify a localized response.
- In the simplified final cascade, prothrombin becomes thrombin; thrombin catalyses conversion of soluble fibrinogen into insoluble fibrin. The mesh reinforces the plug and traps cells, limiting blood loss and pathogen entry. Platelets and red cells do not become fibrin; the cascade must be controlled to avoid obstructing normal circulation.

Which sequence correctly describes the simplified final clotting reactions?
Dificultad 1/5 · 100 monedas + un pequeño bono en el primer intento de hoy
Thrombin is the enzyme; fibrinogen is the soluble precursor and fibrin forms the reinforcing mesh. Platelets support a plug and reactions without turning into fibrin.
Follow phagocytosis into an enclosed compartment
- A phagocyte can leave a small blood vessel, move through tissues, recognize an appropriate target and surround it with membrane. The enclosed material enters a vesicle; lysosomal enzymes digest it within the cell, separated from the rest of the cytoplasm.
- Innate recognition responds to broad microbial or damage features without requiring prior exposure to that exact antigen. Adaptive responses select cells with more specific receptors and can generate memory. The systems cooperate: suitable antigen-presenting cells help activate helper T cells. A phagocyte is neither a red cell nor a secreted antibody.
Keep antigens, receptors and antibodies distinct
- An antigen is a molecular structure recognized by a specific antibody or immune receptor. It need not be an entire organism or necessarily harmful: normal self components, including blood-cell surface antigens, can be recognized. Compatibility and context matter, rather than “antigen” simply meaning any foreign poison.
- Many lymphocyte clones already carry different receptor specificities before exposure. A matching target helps select a compatible clone; it does not teach a randomly chosen receptor to redesign itself. Antibodies are binding proteins made by cells, not living cells that multiply by mitosis.
Explain cooperating clones and their descendants
- In a typical protein-antigen response, a compatible B cell binds and takes up antigen, then displays antigen-derived material. Appropriate helper T-cell recognition and signals support activation; antigen-presenting cells also help activate helper T cells. Not every B cell is activated, and not all immune responses use an identical route.
- Selected cells divide by mitosis in clonal expansion. Plasma-cell descendants secrete many antibodies with the relevant binding specificity; memory populations can persist. Blood and lymph transport cells, while lymphoid tissues such as lymph nodes bring cells and antigen together. Binding can neutralize a target or help other mechanisms remove it.

Interpret immune memory through timing and peak size
- In a separate invented numerical comparison using the same detection rule, a primary antibody response exceeds the threshold after six days and peaks at 20 units; a later response exceeds it after two days and peaks at 100. The peak is fivefold, a 400% increase; the detection delay is four days shorter, a 66.7% decrease.
- Faster activation and expansion of memory populations help explain the secondary response. Use the supplied detection times for the calculation; the schematic curves below do not show that threshold. The first detected point is not necessarily the first antibody molecule made. Antigen change, waning protection and infection site can limit protection: memory does not guarantee lifelong prevention of every infection, and different cold viruses need not be the same challenge.

In an invented comparison using one detection rule, response delay falls from six days to two. Find percentage decrease relative to six days.
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
(6 − 2)/6 × 100 = 66.666…%, about 66.7%. A first detected response is not necessarily the first antibody molecule produced.
Explain HIV through its target and transmission route
- HIV damages CD4 helper T cells and can weaken immune coordination, including effective B-cell help. HIV infection is distinct from AIDS, the advanced syndrome of severe immune damage. Effective antiretroviral treatment can suppress replication and preserve immune function; rapid progression is not inevitable. NIH explains the distinction.
- CDC describes transmission through appropriate infectious fluids reaching susceptible tissue or blood, including sexual exposure, contaminated injection equipment, pregnancy, birth or breastfeeding. Ordinary touching, shared classroom air and mosquitoes do not transmit HIV. Explain a biological route without stigmatizing people or assuming mere proximity is exposure.
Match antibiotics to cellular targets
- Antibiotics can inhibit bacterial cell-wall synthesis, bacterial ribosome function or other bacterial processes. Viruses lack those bacterial targets, so the same mechanism does not treat a viral infection. Treating a secondary bacterial infection during a viral illness does not mean the drug directly kills the virus.
- A clear zone in an approved bacterial-disc test shows inhibited growth under those conditions, not a proven safe medicine for people. Control organism, inoculum, medium, disc dose, incubation and measurement; use suitable controls and repeats. Discovery also needs mechanism, toxicity and effectiveness evidence, while resistance to several drugs can accumulate through different genes or mechanisms.
Track resistance as both a count and a fraction
- In an invented population, 100 of 10,000 bacteria are resistant: 1%. After exposure, 50 resistant and 99 susceptible cells remain. The resistant fraction is 50/149, about 33.6%, although the resistant count has fallen from 100 to 50. Differential survival changes composition; later reproduction can expand survivors.
- Mutation and acquired resistance genes supply heritable variation; antibiotic exposure selects among variants rather than making bacteria choose a useful mutation. A greater fraction is not automatically a greater absolute count. Appropriate use and infection prevention can reduce selection and spread without guaranteeing that resistance never evolves.
An invented post-exposure population has 50 resistant and 99 susceptible bacteria. Find percentage resistant among survivors.
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
50/(50 + 99) × 100 ≈ 33.6%. Use all survivors as denominator. The resistant count may have fallen even while its fraction rises.
Separate an animal reservoir from a vector and a human route
- A zoonosis can pass naturally between other vertebrate animals and humans. Cattle-associated Mycobacterium bovis can infect people, including through contaminated unpasteurized dairy products; it differs from mainly human-associated M. tuberculosis. Rabies virus can enter through an infected mammal's saliva in a bite. CDC gives the bovine-TB distinction.
- For Japanese encephalitis, Culex mosquitoes transmit virus maintained among pigs and water birds; humans generally do not sustain the mosquito cycle. WHO describes that cycle. An animal origin need not mean every later infection comes directly from an animal. Animal-virus relatives of SARS-CoV-2 alone cannot identify its precise first spillover route or prove a named intermediate host.
Connect vaccination with memory and a defined outcome
- Vaccines present chosen antigens or instructions for making one, supporting specific activation, expansion and memory without requiring the natural disease. Types include weakened or inactivated pathogens, purified components and nucleic-acid approaches. Making one antigen from mRNA does not amount to producing a whole reproducing virus; boosters can strengthen or renew responses.
- Define protection against infection, severe disease or transmission separately. A benefit against one is not automatically the same against the others. Evaluation needs comparable groups, clear outcomes, follow-up and assessment of harms as well as benefits; low risk does not mean zero adverse effects, and an early media claim is not a complete study.
Compare absolute risk with relative protection
- In an invented comparison with equal follow-up, 80 of 1,000 unvaccinated participants and 20 of 1,000 vaccinated participants develop the stated outcome. Risks are 8% and 2%, the risk ratio is 0.25 and the relative reduction is 75%. The absolute difference is six percentage points, not 75 percentage points.
- These calculations alone do not prove comparable exposure or causal protection. Randomization or appropriate adjustment, complete follow-up, reliable case detection and uncertainty estimates strengthen inference. State the measured endpoint: a severe-disease risk reduction cannot simply be inserted as protection against transmission.
In an invented equal-follow-up comparison, defined-outcome risks are 8% in an unvaccinated group and 2% in a vaccinated group. Calculate relative risk reduction as a percentage.
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
(1 − 2/8) × 100 = 75%. The absolute difference is six percentage points. Study design and measured endpoint still matter.
State the assumptions of a herd-immunity model
- Herd immunity concerns indirect protection when immunity reduces transmission. In a uniformly mixing teaching model, R-zero is the average secondary-case number in an otherwise susceptible population, and p is the fraction completely protected against contributing to transmission. If R-zero is four, p = 0.80 gives R = 0.8; p = 0.60 gives R = 1.6.
- The immune boundary is 1 minus the reciprocal of R-zero: 75% here. At exactly 75%, R equals one; average decline requires a greater fraction under these assumptions. R below one does not mean no new case can occur. Severity and transmissibility are different properties.

In the uniformly mixing teaching model R = R-zero × (1 − p), R-zero is four and p = 0.80 is complete protection against contributing to transmission. Find R.
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
4 × (1 − 0.80) = 0.8. This is below one, so average chains decline under the assumptions; it does not guarantee zero cases.
Distinguish vaccination coverage from effective protection
- In a further simplified model, let v be vaccinated fraction and e protection against contributing to transmission, so p = ve. If R-zero is four and e = 0.90, the coverage boundary is 0.75/0.90, about 83.3%. Average decline requires coverage above this boundary, rather than exactly the boundary.
- Uniform mixing, otherwise susceptible people and stable protection are assumptions. Clustering, waning protection and variant differences can change outcomes. Do not treat coverage as automatically equal to immunity, or a model boundary as a universal practical guarantee. Use the endpoint relevant to transmission rather than substituting a severe-disease percentage.
Use the simplified model p = v × e. A complete-immunity boundary is p = 0.75 and transmission protection is e = 0.90. Find vaccination-coverage boundary v as a percentage.
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
v = 0.75/0.90 = 0.83333…, or about 83.3%. At the exact boundary R = 1; decline requires greater coverage under the stated assumptions.
Name the denominator, time window and case definition
- Prevalence concerns existing cases at a stated time or period; incidence concerns new cases over a specified interval with a suitable at-risk or person-time denominator. A cumulative reported total is not the number currently ill. Counts can also differ because testing, detection and reporting change.
- In an invented monthly comparison, A has 24 new cases among 800 initially at-risk people, and B has 36 among 1,600: risks are 3% and 2.25%, or 30 and 22.5 per 1,000. A has fewer cases but a higher risk. The risk ratio A/B is about 1.33; the absolute difference is 0.75 percentage points.
Interpret historical reports in their actual units
- WHO situation report 1, published 21 January 2020 with data through 20 January, reported 282 confirmed cases globally; report 2, published the next day with data through 21 January, reported 314. The increase is 32, about 11.3% relative to 282. These historical reports do not count every infection acquired between their publication dates.
- CDC's historical US TB table gives annual 2022 and 2023 incidence rates of 2.5 and 2.9 per 100,000: 25 and 29 per million. The displayed difference is four per million per year. They are rounded TB-disease surveillance rates, not all latent infections or current prevalence. Compare equivalent definitions and periods before explaining a trend.
The cited historical TB table displays annual incidence of 2.5 cases per 100,000. Convert this displayed rate to cases per million people per year.
Dificultad 2/5 · 140 monedas + un pequeño bono en el primer intento de hoy
One million is ten times 100,000, so 2.5 × 10 = 25 per million per year. This is annual TB-disease incidence, not the number of all latent infections.
Build an immune explanation and an evidence comparison
- Trace the relevant actors: platelets support sealing, phagocytes engulf, selected lymphocytes expand, plasma cells secrete binding proteins and memory supports later responses. Explain how HIV, bacterial resistance or antigen change affects a particular stage rather than saying every defence works identically.
- For data, label the outcome, denominator, period and uncertainty. Percentage change uses the initial value; a requested symmetric percentage difference may instead use the mean—state the convention. For invented totals 400 and 500, these give 25% and about 22.2% respectively. Use supplied data or safe contact-network simulations, not cultures of unknown pathogens.
Explain a faster secondary antibody response, then evaluate a claim that a 75% reduction in a vaccine study guarantees no infection once exactly 75% of people are vaccinated.
Mechanistic immune reasoning and population-risk arithmetic answer related but distinct questions. State each link and assumption.